CStone Pharmaceuticals (HKG:2616)
Hong Kong · Delayed Price · Currency is HKD 4.190
-0.160 (-3.68%)
Jul 30, 2026, 4:08 PM HKT
CStone Pharmaceuticals Market Cap
CStone Pharmaceuticals has a market cap or net worth of 6.95 billion as of July 30, 2026. Its market cap has decreased by -39.23% in one year.
Market Cap
6.95B
Enterprise Value
6.27B
Revenue
299.99M
Ranking
n/a
PE Ratio
n/a
Stock Price
4.19
ChartMarket Cap Chart
Since February 26, 2019, CStone Pharmaceuticals's market cap has decreased from 12.65B to 6.95B, a decrease of -45.06%. That is a compound annual growth rate of -7.75%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 29, 2026 | 6.95B | -10.50% |
| Dec 31, 2025 | 7.77B | 164.57% |
| Dec 31, 2024 | 2.94B | 1.52% |
| Dec 29, 2023 | 2.89B | -47.58% |
| Dec 30, 2022 | 5.52B | -42.71% |
| Dec 31, 2021 | 9.63B | -16.96% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Feb 26, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ascletis Pharma | 9.73B |
| Suzhou Ribo Life Science | 9.13B |
| Everest Medicines | 8.86B |
| TenNor Therapeutics (Suzhou) | 8.75B |
| CARsgen Therapeutics Holdings | 8.43B |
| Lepu Biopharma | 8.01B |
| Alphamab Oncology | 7.75B |
| Abbisko Cayman | 7.53B |